Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
Nina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
European Heart Journal (2023) Vol. 45, Iss. 10, pp. 837-849
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Dominik Linz, Jason G. Andrade, Elena Arbelo, et al.
EP Europace (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 38
2024 Chinese Expert Consensus Guidelines on the Diagnosis and Treatment of Atrial Fibrillation in the Elderly, Endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular branch): Executive Summary
Yutang Wang, Yutao Guo, M. Qin, et al.
Thrombosis and Haemostasis (2024) Vol. 124, Iss. 10, pp. 897-911
Open Access | Times Cited: 38
Atrial fibrillation burden: a new outcome predictor and therapeutic target
Nina Becher, Andreas Metzner, Tobias Toennis, et al.
European Heart Journal (2024) Vol. 45, Iss. 31, pp. 2824-2838
Open Access | Times Cited: 30
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC
George Ntaios, Helmut Baumgartner, Wolfram Doehner, et al.
European Heart Journal (2024) Vol. 45, Iss. 19, pp. 1701-1715
Open Access | Times Cited: 24
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
Giuseppe Boriani, Luigi Gerra, Davide Antonio Mei, et al.
European Journal of Internal Medicine (2024) Vol. 123, pp. 37-41
Open Access | Times Cited: 18
Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation
Prashanthan Sanders, Emma Svennberg, Søren Zöga Diederichsen, et al.
European Heart Journal (2024) Vol. 45, Iss. 29, pp. 2594-2603
Open Access | Times Cited: 12
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
Gregory Y.H. Lip, Julius Nikorowitsch, Susanne Sehner, et al.
European Heart Journal (2024) Vol. 45, Iss. 19, pp. 1733-1737
Open Access | Times Cited: 10
Anticoagulation in Patients With Device‐Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH‐AFNET 6 Trial
Hans‐Christoph Diener, Nina Becher, Susanne Sehner, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 17
Open Access | Times Cited: 10
Evidence Gaps and Lessons in the Early Detection of Atrial Fibrillation: A Prospective Study in a Primary Care Setting (PREFATE Study)
Josep Lluís Clúa-Espuny, Alba Hernández-Pinilla, Delicia Gentille-Lorente, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 119-119
Open Access | Times Cited: 1
Myths and challenges around anticoagulation in atrial fibrillation: A practicing clinician's perspective
Juhani Airaksinen, Ville L. Langén, Konsta Teppo, et al.
European Journal of Clinical Investigation (2025)
Closed Access | Times Cited: 1
Characterization of atrial fibrillation burden using wearables
Konstanze Betz, Dominik Linz, David Duncker, et al.
Herzschrittmachertherapie + Elektrophysiologie (2024) Vol. 35, Iss. 2, pp. 111-117
Open Access | Times Cited: 5
Closed loop stimulation reduces the incidence of atrial high-rate episodes compared with conventional rate-adaptive pacing in patients with sinus node dysfunctions
Ennio Pisanò, Valéria Calvi, Miguel Viscusi, et al.
EP Europace (2024) Vol. 26, Iss. 7
Open Access | Times Cited: 4
Subclinical atrial fibrillation/atrial high-rate episodes: what significance and decision-making?
Giuseppe Boriani, Enrico Tartaglia, Paola Trapanese, et al.
European Heart Journal Supplements (2025) Vol. 27, Iss. Supplement_1, pp. i162-i166
Open Access
Swiss Stroke Society position paper on atrial fibrillation monitoring and management after ischaemic stroke: a shift from understanding the index stroke to preventing the next one
Thomas R. Meinel, Markus Arnold, Laurent Roten, et al.
Schweizerische medizinische Wochenschrift (2025) Vol. 155, Iss. 3, pp. 4170-4170
Open Access
Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association
Wolfram Doehner, Giuseppe Boriani, Tatjana Potpara, et al.
EP Europace (2025) Vol. 27, Iss. 3
Closed Access
Anticoagulation in patients with low-burden atrial fibrillation: new evidence focussing on device-detected AF
Nina Becher, Andreas Metzner, Paulus Kirchhof
Heart (2025), pp. heartjnl-324848
Closed Access
Net Benefit of Anticoagulation in Subclinical Device-Detected Atrial Fibrillation
Aleksi K. Winstén, Ville L. Langén, Juhani Airaksinen, et al.
JAMA Network Open (2025) Vol. 8, Iss. 5, pp. e258461-e258461
Open Access
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes
Selçuk Adabağ, Jane Chen, Rehan Karim
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2301-2303
Open Access | Times Cited: 9
Anticoagulation in device-detected atrial fibrillation: a long journey to find the sweet spot
Emma Svennberg, Søren Zöga Diederichsen
European Heart Journal (2024) Vol. 45, Iss. 10, pp. 850-852
Open Access | Times Cited: 3
Stroke risk in device-detected atrial fibrillation is modulated by the continuum of vascular disease burden
Dominik Linz, Sevasti‐Maria Chaldoupi
European Heart Journal (2024) Vol. 45, Iss. 46, pp. 4917-4919
Open Access | Times Cited: 2
Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry
Alberto Garay, Francesç Formiga, Sergio Raposeiras‐Roubín, et al.
Thrombosis and Haemostasis (2018) Vol. 118, Iss. 05, pp. 929-938
Open Access | Times Cited: 20
Should Patients with Subclinical Atrial Fibrillation Receive Anticoagulation?
James A. Reiffel, Peter R. Kowey, Gerald V. Naccarelli
The American Journal of Medicine (2024) Vol. 137, Iss. 5, pp. 383-385
Open Access | Times Cited: 1
Device-detected atrial sensing amplitudes as a marker of increased risk for new onset and progression of atrial high-rate episodes
Mauro Biffi, Eduardo Celentano, Massimo Giammaria, et al.
Heart Rhythm (2024) Vol. 21, Iss. 9, pp. 1630-1639
Closed Access | Times Cited: 1
Device‐Detected Atrial Fibrillation and the Impact of Prior Stroke in Stroke Prevention
James E. Siegler, James R. Brorson
Journal of the American Heart Association (2024) Vol. 13, Iss. 17
Open Access | Times Cited: 1
Detection of atrial fibrillation after stroke due to large or small vessel disease: systematic review and meta-analysis
Matilda Florentin, Dimitrios Sagris, Panagiotis Tasoudis, et al.
International Journal of Stroke (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top